Continuous glucose monitoring may be linked to a lower risk of death among diabetic patients who use insulin, according to Medical Xpress. The outlet reported the finding on Sunday, September 27, 2026.
Medical Xpress framed the result as a possible mortality benefit rather than a confirmed one. Coverage of the same research from Diabetes In Control asked whether CGM could lower mortality in type 1 diabetes, while srpske.rs reported a 44 percent lower death risk for diabetics on insulin.
Taken together, the headlines point to a study examining death rates among insulin users who monitor glucose continuously compared with those who do not. The available reporting does not describe the study design, the size of the group studied, or how long patients were followed.
Continuous glucose monitoring uses a sensor to track glucose levels through the day, in contrast to fingerstick testing that captures single points in time. The material summarized here does not explain why the technology might be associated with fewer deaths, and no mechanism is offered in the available reporting.
The 44 percent figure appears only in the srpske.rs headline and is not attributed to a named study or journal in the material available. Readers should treat it as a reported result pending the underlying research.
What to watch next: whether the full study is published with its methods and patient data, and whether other researchers reproduce the mortality finding in broader groups of insulin users.
